Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies105
InformedDNA
InformedDNA provides genomics insights to optimize clinical decisions for health organizations in the U.S.
Sector
Subsector
Location
total rounds
total raised
DNA Direct
DNA Direct provides genetic expertise and guidance to healthcare providers and patients through genetic information programs.
Sector
Subsector
Keywords
Location
total rounds
total raised
Insight Medical Genetics
Insight Medical Genetics offers personalized counseling and guidance in genetic medicine.
Sector
Subsector
Location
EpigeneticsRx
EpigeneticsRx provides physicians and patients with a comprehensive training program on genetics, methylation, and nutrigenomics.
Sector
Subsector
Keywords
Location
M&A Details1
Transaction name
Acquired by
Genome Medical
announced date
Financials
Funding Rounds2
Number of Funding Rounds
Money Raised
Their latest funding was raised on 21.07.2020. Their latest investor Casdin Capital. Their latest round Venture - Series Unknown
Co-Investors
Investors1
Number of lead investors
Number of investors
Casdin Capital
Casdin Capital is an investment firm that specializes in the life sciences and healthcare industry.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
People
Founders2
Jill Davies
Jill Davies is the Founder and Chief Executive Officer for GeneMatters. Jill has more than 20 years’ experience in the genetics field, with leadership in clinical services, telehealth, product development, business development and operations. Prior to founding GeneMatters in 2016, Jill was Director of Genetics at the Medcan Clinic in Toronto where she developed and delivered leading-edge clinical genomics services. She has a special interest in the role of genomics in primary care and preventive medicine as well as the use of technology to enable access to genomic information and services.
current job
count Of Investments
Jill Davies
Troy Kopischke
Troy Kopischke is an Executive Board Member of Imbio. Previously, he was the President and Chief Financial Officer for Steady State Imaging where he was instrumental in developing a commercialization strategy that helped guide the sale of the company to GE Healthcare in 2011. In addition, Troy Kopischke has held executive level positions in the product development and electronic products industries including Senior Executive Vice President at Micro Dynamics and Logic Product Development from 2005 to 2008. During his tenure at Micro Dynamics and Logic, his contribution was critical in creating the largest embedded computing module company in the world. From 1999 to 2005 he was the President and Chief Financial Officer of Logic Product Development where he orchestrated dynamic new growth areas of the company. He also served as the Director of Engineering for Logic Product Development from 1999 to 2000. Troy Kopischke holds a B.S.E.E. in Electrical Engineering from the University of Minnesota and a B.A. in Physics and a B.A. in Engineering Science from Bethel College. He is the author of two patents and is the recipient of the Jack Kilby Award from Texas Instruments and the Partner of the Year award from Freescale Semiconductor. Troy Kopischke sits on the Board of Directors of various charitable organizations and enjoys family time, travel and dabbling in French cooking.
current job
organization founded
Troy Kopischke
Employee Profiles3
Hanah Cytron
Genetic counseling assistant, team lead